Summing the risk of NSAID therapy

This publication has 13 references indexed in Scilit:

• Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial
  The Lancet, 2007
• Use of Nonsteroidal Antiinflammatory Drugs
  Circulation, 2007
• Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
  The Lancet, 2007
• Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
  PLoS Clinical Trials, 2006
• Celecoxib for the Prevention of Colorectal Adenomatous Polyps
  New England Journal of Medicine, 2006
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
  BMJ, 2006
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
  Journal of Clinical Investigation, 2005
• Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
  New England Journal of Medicine, 2005
• Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
  New England Journal of Medicine, 2005
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000